[go: up one dir, main page]

AR035273A1 - PRAMIPEXOL FOR THE TREATMENT OF ADHD - Google Patents

PRAMIPEXOL FOR THE TREATMENT OF ADHD

Info

Publication number
AR035273A1
AR035273A1 ARP020102946A ARP020102946A AR035273A1 AR 035273 A1 AR035273 A1 AR 035273A1 AR P020102946 A ARP020102946 A AR P020102946A AR P020102946 A ARP020102946 A AR P020102946A AR 035273 A1 AR035273 A1 AR 035273A1
Authority
AR
Argentina
Prior art keywords
adhd
treatment
pramipexol
tetrahyde
pilamino
Prior art date
Application number
ARP020102946A
Other languages
Spanish (es)
Inventor
Jurgen Reess
Franco Borsini
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of AR035273A1 publication Critical patent/AR035273A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Utilización del 2-amino-4,5,6,7-tetrahido-6-n-pro-pilamino-benzotiazol, su enantiómero (+) o (-), sus sales por adición de ácidos farmacológicamente compatibles así como sus hidratos y solvatos, para la preparación de un medicamento destinado a la prevención y/o al tratamiento del ADHD.Use of 2-amino-4,5,6,7-tetrahyde-6-n-pro-pilamino-benzothiazole, its (+) or (-) enantiomer, its salts by the addition of pharmacologically compatible acids as well as its hydrates and solvates , for the preparation of a medicine intended for the prevention and / or treatment of ADHD.

ARP020102946A 2001-08-03 2002-08-02 PRAMIPEXOL FOR THE TREATMENT OF ADHD AR035273A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10137633A DE10137633A1 (en) 2001-08-03 2001-08-03 Treatment or prophylaxis of attention deficit hyperactivity disorder, using the dopamine agonist pramexipol or its salt

Publications (1)

Publication Number Publication Date
AR035273A1 true AR035273A1 (en) 2004-05-05

Family

ID=7693957

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020102946A AR035273A1 (en) 2001-08-03 2002-08-02 PRAMIPEXOL FOR THE TREATMENT OF ADHD

Country Status (8)

Country Link
EP (1) EP1416930A1 (en)
JP (1) JP2005500368A (en)
AR (1) AR035273A1 (en)
CA (1) CA2453485A1 (en)
DE (1) DE10137633A1 (en)
MX (1) MXPA04001001A (en)
UY (1) UY27408A1 (en)
WO (1) WO2003013520A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200906997A1 (en) 2009-09-11 2011-03-21 Sanovel �La� San. Ve T�C. A. �. Pramipexole pharmaceutical compositions.
TR200907554A1 (en) * 2009-10-06 2011-04-21 Sanovel İlaç San.Ve Ti̇c.A.Ş. Orally dispersible pramipexole compositions.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5621133A (en) * 1989-05-31 1997-04-15 Deninno; Michael P. Dopamine agonists
WO2001089453A2 (en) * 2000-05-19 2001-11-29 Wayne State University Derivatives of 2-aminotetralins and pharmaceutical analogs thereof exhibiting differential cns receptor activity and behavior
US20020016334A1 (en) * 2000-07-31 2002-02-07 Coe Jotham Wadsworth Pharmaceutical composition for the treatment of attention deficit hyperactivity disorder (ADHD)
US6613308B2 (en) * 2000-09-19 2003-09-02 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system

Also Published As

Publication number Publication date
DE10137633A1 (en) 2003-02-20
CA2453485A1 (en) 2003-02-20
JP2005500368A (en) 2005-01-06
EP1416930A1 (en) 2004-05-12
WO2003013520A1 (en) 2003-02-20
UY27408A1 (en) 2003-02-28
MXPA04001001A (en) 2004-04-20

Similar Documents

Publication Publication Date Title
UY28034A1 (en) ELECTED CGRP ANTAGONISTS, PROCEDURE FOR PREPARATION AS WELL AS ITS EMPLOYMENT AS MEDICATIONS
UY28040A1 (en) CGRP ANTAGONISTS ELECTED, PROCEDURE FOR PREPARATION, AS WELL AS ITS EMPLOYMENT AS MEDICATIONS.
ECSP088593A (en) 5- (ARILSULFONIL) -PIRAZOLOPIPERIDINS
UY29919A1 (en) SUBSTITUTED DERIVATIVES OF 3,4-DIHYDROISOQUINOLIN-1-AMINO-TRIFLUOROACETATE, ITS PHARMACEUTICAL COMPOSITIONS AND APPLICATIONS
SV2003001107A (en) IMIDAZOTRIAZINAS REF.LEA 35368
SV2002000169A (en) NEW DERIVATIVES OF AMINODICARBOXILIC ACID WITH PHARMACEUTICAL PROPERTIES REF. READ 33878-SV
ECSP045081A (en) DERIVATIVES OF 1,8-NAFTIRIDINE AND ITS USE FOR THE TREATMENT OF DIABETES AND RELATED DISORDERS
UY29437A1 (en) NEW CGRP ANTAGONISTS
AR002043A1 (en) USE OF ALPHA AGONISTS (1L) FOR THE TREATMENT OF URINARY INCONTINENCE.
UY28859A1 (en) SELECTED CGRP ANTAGONISTS, PROCEDURE FOR PREPARATION AS WELL AS ITS USE AS A MEDICINAL PRODUCT
UA83691C2 (en) Use of substituted 2-aminotetralines for the preventative treatment of parkinson's disease
UY30025A1 (en) SUBSTITUTED DERIVATIVES OF 2-AMINO-5,6-DIHIDRO PIRIMIDIN-4 (3H) -ONAS AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITIONS CONTAINING AND APPLICATIONS.
DK1162982T3 (en) Use of stabilized oligonucleotides to prepare a drug with antitumoral effect
ATE534391T1 (en) 3,11B-CIS-DIHYDROTETRABENAZINE FOR THE TREATMENT OF PSYCHOSES
SE0301446D0 (en) New Compounds
UY30377A1 (en) FUSIONATED TRICYCLE INHIBITORS OF SULFONAMIDE OF GAMA-SECRETASA
ECSP045156A (en) INDOLILALQUILAMINE DERIVATIVES AS LIGANDOS 5-HIDROXITRIPTAMINA-6
CY1110130T1 (en) MORPHOLINE PRODUCTS FOR USE AS DOPAMINE AGONISTS IN THERAPEUTIC DISEASE Therapeutic Treatment I.A.
SV2004001756A (en) NEW DIFENILAZETIDINONA WITH IMPROVED PHYSIOLOGICAL PROPERTIES, PROCEDURE FOR PREPARATION, MEDICINES THAT UNDERSTAND THIS COMPOSITE AND ITS USE
PA8568101A1 (en) INDOLIL-UREA DERIVED FROM USEFUL TIENOPIRIDINS AS ANTIANGIOGEN AGENTS, AND PROCEDURES FOR USE
UY27451A1 (en) 2,5-DIAMIDOINDOLES REPLACED AND ITS USE
ES2193065T3 (en) NEW USE OF THE SAREDUTANT.
AR035273A1 (en) PRAMIPEXOL FOR THE TREATMENT OF ADHD
BR0211223A (en) Substituted 4-aminocyclohexanol derivatives
AR028970A1 (en) USE OF CILANSETRON OR ITS SALTS BY ADDITION OF CIDOS AND / OR PHARMACOLOGICALLY COMPATIBLE SOLVATES FOR THE OBTAINING OF PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT AND / OR PROFILAXIS OF THE IRRITABLE INTESTINE SYNDROME

Legal Events

Date Code Title Description
FA Abandonment or withdrawal